CHICAGO--(BUSINESS WIRE)--Advanced Biotherapy, Inc. (OTCBB:ADVB) announced today that it restated
its 2004 and 2005 audited financial statements and its 2006 quarterly
unaudited...
CHICAGO--(BUSINESS WIRE)--Advanced Biotherapy, Inc. (OTCBB:ADVB) announced today that it plans to
restate its 2005 audited financial statements and its 2006 quarterly
unaudited...
CHICAGO--(BUSINESS WIRE)--Advanced Biotherapy, Inc. (OTCBB:ADVB) announced today that it has
completed the sale of common stock to Richard P. Kiphart and other new
investors in the...
CHICAGO--(BUSINESS WIRE)--Aug. 29, 2006--Advanced Biotherapy, Inc. (OTCBB: ADVB) announced today that it has entered into an agreement to raise $6,500,000 through a sale of stock to Richard P....
#3: ADVB News Advanced Biotherapy Appoints Daniel Levitt, MD, Ph.D., Former President of Research and Development at Protein Design Labs, Inc., to Scientific Advisory Board
WOODLAND HILLS, Calif.--(BUSINESS WIRE)--Dec. 20, 2005--Advanced Biotherapy, Inc. (OTCBB:ADVB) announced today that Dr. Daniel Levitt, Chief Medical Officer and Head of Clinical and Regulatory...
WOODLAND HILLS, Calif.--(BUSINESS WIRE)--Nov. 29, 2005--Advanced Biotherapy, Inc. (OTCBB:ADVB), dedicated to pioneering the development and use of therapeutic antibodies, today provided the...
WOODLAND HILLS, Calif.--(BUSINESS WIRE)--Nov. 14, 2005--Advanced Biotherapy, Inc. (OTCBB:ADVB) announced today that Keith Gregg, managing partner of BioPharm Development Group, LLC, a retained,...
